S. Arebee, A. “CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review”. Libyan Journal of Medical and Applied Sciences, vol. 3, no. 4, Dec. 2025, pp. 102-8, doi:10.64943/ljmas.v3i4.254.